Measurable residual disease detection by high-throughput sequencing improves risk stratification for pediatric B-ALL

Early response to induction chemotherapy is an important prognostic factor in B-lymphoblastic leukemia (B-ALL). Here, we compare high-throughput sequencing (HTS) of IGH and TRG genes vs flow cytometry (FC) for measurable residual disease (MRD) detection at the end of induction chemotherapy in pediat...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Blood
Main Authors: Wood, Brent, Wu, David, Crossley, Beryl, Dai, Yunfeng, Williamson, David, Gawad, Charles, Borowitz, Michael J., Devidas, Meenakshi, Maloney, Kelly W., Larsen, Eric, Winick, Naomi, Raetz, Elizabeth, Carroll, William L., Hunger, Stephen P., Loh, Mignon L., Robins, Harlan, Kirsch, Ilan
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2018
Assuntos:
Lymphoid Neoplasia
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5865233/
https://ncbi.nlm.nih.gov/pubmed/29284596
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2017-09-806521
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados